Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1982 1
1983 1
1985 2
1986 1
1987 1
1989 2
1991 2
1992 4
1993 1
1994 1
1995 1
1996 1
2001 1
2004 1
2005 1
2010 1
2012 1
2013 2
2016 1
2017 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
Enhancing the function of CD34(+) cells by targeting plasminogen activator inhibitor-1.
Hazra S, Stepps V, Bhatwadekar AD, Caballero S, Boulton ME, Higgins PJ, Nikonova EV, Pepine CJ, Thut C, Finney EM, Stone DJ, Bartelmez SH, Grant MB. Hazra S, et al. Among authors: bartelmez sh. PLoS One. 2013 Nov 1;8(11):e79067. doi: 10.1371/journal.pone.0079067. eCollection 2013. PLoS One. 2013. PMID: 24223881 Free PMC article.
Transient inhibition of transforming growth factor-beta1 in human diabetic CD34+ cells enhances vascular reparative functions.
Bhatwadekar AD, Guerin EP, Jarajapu YP, Caballero S, Sheridan C, Kent D, Kennedy L, Lansang MC, Ruscetti FW, Pepine CJ, Higgins PJ, Bartelmez SH, Grant MB. Bhatwadekar AD, et al. Among authors: bartelmez sh. Diabetes. 2010 Aug;59(8):2010-9. doi: 10.2337/db10-0287. Epub 2010 May 11. Diabetes. 2010. PMID: 20460428 Free PMC article.
28 results